suPAR: The unspecific marker for disease presence, severity and prognosis
- 1 December 2015
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 46, S33-S34
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency departmentInternal and Emergency Medicine, 2015
- Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patientsJournal of Critical Care, 2014
- Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndromeClinical Biochemistry, 2013
- Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewIntensive Care Medicine, 2012
- Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsisJournal of Infection, 2011
- Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general populationJournal of Internal Medicine, 2010
- Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV‐infected patients receiving highly active antiretroviral therapyJournal of Medical Virology, 2007
- Development and Validation of a Multiplex Add-On Assay for Sepsis Biomarkers Using xMAP TechnologyClinical Chemistry, 2006
- Plasma Concentrations of Soluble Urokinase‐Type Plasminogen Activator Receptor Are Increased in Patients with Malaria and Are Associated with a Poor Clinical or a Fatal OutcomeThe Journal of Infectious Diseases, 2005
- The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortalityClinical Microbiology and Infection, 2004